300146.SZ SHZ
By-health Co., Ltd.
1W: +0.0%
1M: -3.8%
3M: +1.2%
YTD: -24.4%
1Y: -20.9%
3Y: -50.0%
5Y: -64.0%
¥9.43 ($1.41)
+0.14 (+1.51%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$6.2B
-9.1% ▼
5Y CAGR: +0.4%
Gross Profit
$4.0B
-11.0% ▼
5Y CAGR: +1.0%
Operating Income
$888M
+7.9% ▲
5Y CAGR: -13.1%
Net Income
$782M
+19.8% ▲
5Y CAGR: -12.5%
EPS (Diluted)
$0.47
+23.7% ▲
5Y CAGR: -13.3%
EBITDA
$1.2B
+22.3% ▲
5Y CAGR: -5.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $7.4B | $7.9B | $9.4B | $6.8B | $6.2B |
| YoY Growth | +21.9% | +5.8% | +19.7% | -27.3% | -9.1% |
| Cost of Revenue | $2.5B | $2.5B | $2.9B | $2.3B | $2.2B |
| Gross Profit | $4.9B | $5.4B | $6.5B | $4.5B | $4.0B |
| Gross Margin | 65.8% | 68.1% | 68.8% | 66.1% | 64.7% |
| R&D Expenses | $150M | $158M | $179M | $149M | $82M |
| SG&A Expenses | $2.9B | $3.6B | $4.4B | $3.6B | $3.0B |
| Operating Expenses | $2.9B | $3.7B | $4.4B | $3.7B | $3.1B |
| Operating Income | $2.0B | $1.6B | $2.1B | $824M | $888M |
| Operating Margin | 27.3% | 20.5% | 22.0% | 12.0% | 14.3% |
| Interest Expense | $11M | $3M | $5M | $14M | $16M |
| Income Before Tax | $2.2B | $1.7B | $2.2B | $901M | $1.0B |
| Tax Expense | $412M | $294M | $417M | $253M | $192M |
| Net Income | $1.8B | $1.4B | $1.7B | $653M | $782M |
| Net Margin | 23.6% | 17.6% | 18.6% | 9.5% | 12.6% |
| EPS (Diluted) | $1.05 | $0.81 | $1.03 | $0.38 | $0.47 |
| EBITDA | $2.0B | $1.8B | $2.1B | $964M | $1.2B |
| Shares Outstanding | 1.70B | 1.70B | 1.70B | 1.72B | 1.68B |